» Articles » PMID: 35920986

The Multifaceted Mechanisms of Malignant Glioblastoma Progression and Clinical Implications

Overview
Specialty Oncology
Date 2022 Aug 3
PMID 35920986
Authors
Affiliations
Soon will be listed here.
Abstract

With the application of high throughput sequencing technologies at single-cell resolution, studies of the tumor microenvironment in glioblastoma, one of the most aggressive and invasive of all cancers, have revealed immense cellular and tissue heterogeneity. A unique extracellular scaffold system adapts to and supports progressive infiltration and migration of tumor cells, which is characterized by altered composition, effector delivery, and mechanical properties. The spatiotemporal interactions between malignant and immune cells generate an immunosuppressive microenvironment, contributing to the failure of effective anti-tumor immune attack. Among the heterogeneous tumor cell subpopulations of glioblastoma, glioma stem cells (GSCs), which exhibit tumorigenic properties and strong invasive capacity, are critical for tumor growth and are believed to contribute to therapeutic resistance and tumor recurrence. Here we discuss the role of extracellular matrix and immune cell populations, major components of the tumor ecosystem in glioblastoma, as well as signaling pathways that regulate GSC maintenance and invasion. We also highlight emerging advances in therapeutic targeting of these components.

Citing Articles

Lavender Essential Oil and Its Terpenic Components Negatively Affect Tumor Properties in a Cell Model of Glioblastoma.

Russo M, Martella N, Gargano D, Fantasma F, Marcovecchio C, Russo V Molecules. 2025; 29(24.

PMID: 39770132 PMC: 11676467. DOI: 10.3390/molecules29246044.


Exploring miRNA therapies and gut microbiome-enhanced CAR-T cells: advancing frontiers in glioblastoma stem cell targeting.

Sandhanam K, Tamilanban T, Bhattacharjee B, Manasa K Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39382681 DOI: 10.1007/s00210-024-03479-9.


Glioma-Stem-Cell-Derived Exosomes Remodeled Glioma-Associated Macrophage via NEAT1/miR-125a/STAT3 Pathway.

Pan T, Xie D, Li J, Qiang Y, Fan S, Wang T Cancers (Basel). 2024; 16(14).

PMID: 39061140 PMC: 11274466. DOI: 10.3390/cancers16142500.


Epithelial UNC-23 limits mechanical stress to maintain glia-neuron architecture in C. elegans.

Martin C, Bent J, Hill T, Topalidou I, Singhvi A Dev Cell. 2024; 59(13):1668-1688.e7.

PMID: 38670103 PMC: 11233253. DOI: 10.1016/j.devcel.2024.04.005.


Border-associated macrophages in the central nervous system.

Sun R, Jiang H J Neuroinflammation. 2024; 21(1):67.

PMID: 38481312 PMC: 10938757. DOI: 10.1186/s12974-024-03059-x.


References
1.
Bao S, Wu Q, McLendon R, Hao Y, Shi Q, Hjelmeland A . Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120):756-60. DOI: 10.1038/nature05236. View

2.
Albrengues J, Shields M, Ng D, Park C, Ambrico A, Poindexter M . Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018; 361(6409). PMC: 6777850. DOI: 10.1126/science.aao4227. View

3.
Codega P, Mellinghoff I . Dissecting Glioma Invasiveness in a 3D-Organotypic Model. Trends Mol Med. 2017; 23(9):776-777. PMC: 5588876. DOI: 10.1016/j.molmed.2017.07.009. View

4.
Couturier C, Ayyadhury S, Le P, Nadaf J, Monlong J, Riva G . Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy. Nat Commun. 2020; 11(1):3406. PMC: 7343844. DOI: 10.1038/s41467-020-17186-5. View

5.
Taylor T, Furnari F, Cavenee W . Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance. Curr Cancer Drug Targets. 2012; 12(3):197-209. PMC: 3464093. DOI: 10.2174/156800912799277557. View